Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Lyles

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Clinical Therapeutics|March 18, 2008
Alzheimer's disease: the specter of fragmented policy and financingAlan Lyles
Clinical Therapeutics|February 27, 2009
Adapting pharmacoeconomic data and methods to extend the postpublication utility of analysesAlan Lyles
Clinical Therapeutics|November 1, 2011
National versus international generalizations from cost-effectiveness analysesAlan Lyles
Clinical Therapeutics|February 14, 2012
Price and value: the pharmacoeconomics of scarcityAlan Lyles
Annual Review of Public Health|March 23, 2002
Direct marketing of pharmaceuticals to consumersAlan Lyles
Clinical Therapeutics|December 22, 2005
Evidence gaps in complementary and alternative medicine useAlan Lyles
Clinical Therapeutics|June 22, 2002
The prescription drug user fee act: active postmarketing drug surveillance and safetyAlan Lyles
Clinical Therapeutics|March 15, 2003
The brief history and uncertain future of prescription drug benefitsAlan Lyles
Clinical Therapeutics|December 5, 2002
Peer review and evidence-based decisionsAlan Lyles
Clinical Therapeutics|March 15, 2005
Resolutions, national goals, and health disparitiesAlan Lyles
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Clinical Therapeutics|March 18, 2008
Alzheimer's disease: the specter of fragmented policy and financingAlan Lyles
Clinical Therapeutics|February 27, 2009
Adapting pharmacoeconomic data and methods to extend the postpublication utility of analysesAlan Lyles
Clinical Therapeutics|November 1, 2011
National versus international generalizations from cost-effectiveness analysesAlan Lyles
Clinical Therapeutics|February 14, 2012
Price and value: the pharmacoeconomics of scarcityAlan Lyles
Annual Review of Public Health|March 23, 2002
Direct marketing of pharmaceuticals to consumersAlan Lyles
Clinical Therapeutics|December 22, 2005
Evidence gaps in complementary and alternative medicine useAlan Lyles
Clinical Therapeutics|June 22, 2002
The prescription drug user fee act: active postmarketing drug surveillance and safetyAlan Lyles
Clinical Therapeutics|March 15, 2003
The brief history and uncertain future of prescription drug benefitsAlan Lyles
Clinical Therapeutics|December 5, 2002
Peer review and evidence-based decisionsAlan Lyles
Clinical Therapeutics|March 15, 2005
Resolutions, national goals, and health disparitiesAlan Lyles
Pageof 7